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Abstract In adipose tissue, the microsomal enzyme 1,2-
acyl CoA:diacylglyceroltransferase-1 (DGAT1) plays an im-
portant role in triglyceride storage. Because DGAT1 is ex-
pressed in skeletal muscle as well, we aimed to directly test
the effect of DGAT1 on muscular triglyceride storage by
overexpressing DGAT1 using in vivo DNA electroporation.
A pcDNA3.1-DGAT1 construct in saline was injected in the
left tibialis anterior muscle of rats, followed by the applica-
tion of eight transcutaneous pulses, using the contralateral
leg as sham-electroporated control. Electroporation of the
DGAT1 construct led to significant overexpression of the
DGAT1 protein. The functionality of DGAT1 overexpression
is underscored by the pronounced diet-responsive increase
in intramyocellular lipid (IMCL) storage. In chow-fed rats,
DGAT1-positive myocytes showed significantly higher IMCL
content compared with the control leg, which was almost de-

















 0.05). High-fat feeding increased IMCL
levels in both DGAT1-positive and control myocytes, result-

















 0.05).  Our
findings indicate that DGAT1 contributes to the storage of
IMCL and that in vivo DNA electroporation is a promising
tool to examine the functional consequences of altered
gene expression in mature skeletal muscle.
 
—Roorda, B. D.,
M. K. C. Hesselink, G. Schaart, E. Moonen-Kornips, P. Mar-
tínez-Martínez, M. Losen, M. H. De Baets, R. P. Mensink,
and P. Schrauwen. 
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In addition to white adipose tissue, fatty acids can be
stored in nonadipose tissues, such as heart, liver, and skel-
etal muscle. In skeletal muscle, fatty acids are stored as
lipid droplets mostly in the vicinity of the mitochondria,
 
where they may serve as a rapid available energy store (1).
In highly trained subjects, the level of these intramyocellu-
lar lipids (IMCLs) is increased (2), and endurance train-
ing in previously untrained subjects increases IMCL levels
after only 2 weeks (3). These findings are compatible with
a role for IMCL as a substrate to fuel muscle, especially
during prolonged exercise. However, increased IMCL can
also be the consequence of increased fatty acid availability,
such as after intravenous lipid infusion (4, 5), on a high-
fat diet (6, 7), and in type 2 diabetes mellitus and/or obe-
sity (8).
Despite these findings, little is known about the regula-
tion of triglyceride storage in muscle. In adipose tissue,
the microsomal enzyme 1,2-acyl CoA:diacylglyceroltrans-
ferase (DGAT) may play an important role in triglyceride
storage. DGAT catalyzes the final step in triacylglycerol
synthesis by using diacylglycerol and fatty acyl CoAs as sub-
strates. Two isoforms of DGAT have been discovered,
DGAT1 and DGAT2, which are members of different fam-
ilies of genes. DGAT1 is widely expressed in all tissues,
with high expression in white adipose tissue, skeletal mus-
cle, and intestine (9), whereas the expression of DGAT2 is
restricted to liver and adipose tissue (10). To test DGAT1
functionality, Chen et al. (11) generated transgenic mice
with white adipose tissue-specific overexpression. These
mice had increased adipocyte size, increased adipose
mass, and increased susceptibility to high-fat diet-induced
obesity compared with wild-type mice. The increased adi-
posity was limited to adipose tissue and did not affect the
liver and skeletal muscle, indicating that, at least in white
adipose tissue, DGAT1 has a direct effect on triglyceride
storage (11). On the other hand, transgenic DGAT1-defi-
cient mice have normal plasma triglyceride levels but abun-
dantly store triglycerides in their adipose tissue, probably
attributable to the remnant activity of DGAT2 (12). Inter-
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eride levels in skeletal muscle, suggesting that DGAT1
plays a key role in triglyceride storage in muscle. However,
DGAT1-deficient mice are also characterized by increased
energy expenditure, leaving open the possibility that the
reduced IMCL levels in DGAT1-deficient mice are the re-
sult of increased use of these IMCLs.
Therefore, to directly test the role of DGAT1 in triglyc-
eride storage in skeletal muscle, we overexpressed DGAT1
in skeletal muscle of rats in vivo. To this end, we used the
unique in vivo DNA electroporation technique to achieve
overexpression of the DGAT1 protein. In vivo DNA elec-
troporation has been shown to be very successful for the
transfection of genes, especially in skeletal muscle (13). A
major advantage of this methodology is that DGAT1 can
be overexpressed locally, in one specific skeletal muscle,
allowing the use of the corresponding muscle in the con-
tralateral leg as an internal control. Therefore, many po-
tential confounding factors, such as substrate endocrine
milieu or dietary intake, are identical in overexpression vs.
control muscle. In addition, using in vivo DNA electropo-
ration techniques, the protein of interest is expressed
within a couple of days. This is an advantage over tradi-
tional lifelong overexpression of the protein of interest
in transgenic mice, which often results in compensatory
changes in other proteins, thereby affecting the overall
phenotype of the transgenic animal. To test the function-
ality of DGAT1 overexpression, lipid accumulation was ex-
amined in DGAT1-transfected muscle of adult rats fed ei-









10.2 g at the onset of the study, were housed individually in envi-




C) with a 12 h/12 h
light/dark-cycle (light from 7:00 AM to 7:00 PM). During the ex-
periments, rats had free access to tap water and food. All experi-
ments were approved by the Institutional Animal Care and Use
Committee and complied with the principles of laboratory ani-
mal care.
 
Injection of the construct and electroporation
 
An in vivo DNA electroporation technique was used to obtain
specific overexpression of DGAT1 in the left tibialis anterior
(TA) muscle of the rat, whereas the right TA muscle served as a
sham-electroporated internal control. DNA electroporation was
performed under halothane anesthesia. Left TA muscles were in-












l) of pcDNA3.1-DGAT1 construct
containing a FLAG-tagged epitope (kindly provided by Dr. R.
Farese, Jr., J. David Gladstone Institutes) in 0.9% sterile NaCl.




l of 0.9% sterile NaCl
as a control. Five minutes after injection, eight transcutaneous
electric pulses were applied by two stainless steel plate electrodes
placed at each side of the leg to obtain transient permeabiliza-
tion of the cell membrane, facilitating the passage of the injected
construct. Impedance was minimized by shaving the leg and the
application of a conductive gel. Four square wave pulses followed
by four pulses of the opposite polarity were generated by an ECM
820 electroporator (BTX, San Diego, CA). The ratio of applied




Immediately after electroporation, rats were randomly divided




 5) received a regular chow low-





 3) was placed on a high-fat diet (46% energy from
fat). Both diets were purchased from Hope Farms (Woerden,
The Netherlands) and provided ad libitum.
 
Tissue sampling and staining
 
Fifteen days after DNA electroporation, tissue dissection was
performed under ketamine (Nimatek; 1.0 ml/kg) and xylazine
(Sedamun; 0.5 ml/kg) anesthesia by subcutaneous injection.
Left and right TA muscles were dissected carefully, and any visi-
ble fat and blood were removed. The mid belly was embedded in
Tissue-Tek (Sakura Finetek Europe, Zoeterwoude, The Nether-
lands) and rapidly frozen in liquid nitrogen-cooled isopentane








C until further analysis. Immediately after tis-
sue sampling, rats were killed by cervical dislocation.




m) were thaw mounted on uncoated
precleaned (96% ethanol) glass slides. Air-dried cryosections
from the electroporated and control TA muscles were fixed in
3.7% formaldehyde (Merck, Darmstadt, Germany) in deionized




C. Formaldehyde-fixed sections were rinsed
three times in deionized water for 30s to remove excess formal-
dehyde. The sections were then treated with 0.5% Triton X-100
(Merck) in PBS for 5 min, washed with three exchanges of PBS
for 5 min, and processed for combined oil red O (ORO) and im-
munofluorescence staining according to Koopman, Schaart, and
Hesselink (14). In brief, sections were incubated with an anti-
body against the basement membrane protein laminin (Sigma-
Aldrich, St. Louis, MO; 1:40 dilution) in PBS for 30 min at room
temperature to define the myocellular border. Sections for the
determination of fiber types were coincubated with A4.951-myo-
sin heavy chain 1 antibody [Developmental Studies Hybridoma
Bank (DSHB), Iowa City, IA; 1:50 dilution]. Incubation was fol-
lowed by washing with one exchange of PBS and two exchanges
of TBS for 5 min each. Next, sections were incubated with FITC-
conjugated anti-FLAG antibody (Sigma-Aldrich; 1:100 dilution)
for visualization of overexpressed DGAT1 or with Alexafluor 488-
labeled goat anti-mouse IgG 1488 (Molecular Probes, Leiden,
The Netherlands; 1:200 dilution) and Alexafluor 488-labeled
goat anti-rat IgG1 Alexa 350 (Molecular Probes; 1:130 dilution)
in TBS for 30 min at room temperature. After washing with one
exchange of TBS and two exchanges of PBS for 5 min each, glass
slides were immersed in the ORO working solution for 30 min
for the detection of lipid droplets. The working solution consists
of a 36% triethylphosphate solution containing 12 ml of ORO
stock solution and 8 ml of deionized water. The working solution
was filtered through Whatman paper number 42 (Whatman,
Maidstone, UK) to remove crystallized ORO. The stock solution
was made by adding 500 mg of ORO (Fluka Chemie, Buchs, Swit-
zerland) to 60 ml of triethylphosphate (Fluka Chemie) and 40
ml of deionized water. After ORO staining, slides were rinsed
three times with deionized water for 30s followed by 10 min of
washing with running tap water. Stained sections were embedded
in Mowiol.
 
Image capturing, processing, and analysis
 
All sections were examined using a Nikon E800 fluorescence
microscope (Uvikon, Bunnik, The Netherlands) coupled to a
Basler A101C progressive scan color charge-coupled device cam-
era. Multiple random images were captured for every single
color (red, green, and blue) from all sections and processed and
analyzed using Lucia GF 4.80 software (Nikon, Düsseldorf, Ger-
many). Special care was taken to use the same camera settings
(gain and exposure time) while grabbing all images.
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All images were analyzed for the number of myocytes overex-
pressing DGAT1 and for the lipid droplet over myocyte area frac-





) autodetection of the cellular membrane (identified in









) measurement of the area covered by lipid
droplets (identified in the red channel); and 4) measurement of
the intensity of the fluorescent stain yielded by the anti-FLAG
FITC [identified in the green channel and represented at an
8 bit level; 0–255 arbitrary units (AU)], representing overex-
pressed DGAT1. The area fraction was computed by dividing the
area covered by lipid droplets in micrometers squared by the
area covered by the measured myocytes in micrometers squared.
Measuring background intensity of the anti-FLAG FITC in the
sham-electroporated control leg revealed that in every single cell
the intensity of the green signal did not exceed 40 AU. There-





as DGAT1-positive myocytes. The efficiency of transfection was





40 AU over the total number of myocytes examined in the
DGAT1-electroporated muscle. In total, 1,105 myocytes were ex-
amined for DGAT1 expression and lipid droplet content in the
electroporated leg. In the contralateral leg, devoid of exogenous
DGAT1 protein and therefore exhibiting low intermyocellular




Impact of in vivo DNA electroporation on
muscle structure
 
The effect of in vivo DNA electroporation on muscle
structure was examined using routine light microscopy.
Muscles were screened for the well-known markers of
muscle damage, such as centrally located nuclei, mem-
brane disruption, and macrophage infiltration. Fifteen
days after electroporation, light microscopic examination
revealed no signs of muscle damage (data not shown).
These findings indicate that electroporation was well tol-
erated by the animals and that 15 days after electropora-
tion muscle structure was normal.
 
In vivo DNA electroporation of DGAT1 in muscle
 
Electroporation of the pcDNA3.1-DGAT1 construct
into the TA muscle of rats in vivo led to a significant in-
crease in green fluorescence intensity compared with the

















 0.001). Thus, DGAT1-positive
myocytes could easily be distinguished from DGAT1-nega-
tive myocytes by the detection of green fluorescence from
the FLAG-tagged antibody. The efficiency of transfection





In skeletal muscle, different muscle fiber types can be
distinguished by marked differences in oxidative capacity.
Type I muscle fibers have the highest oxidative capacity,
whereas type II muscle fibers are highly glycolytic. In healthy
control muscles, the majority of IMCLs are confined to
the oxidative type I muscle fibers. To test if an effect of
DGAT1 overexpression on IMCL content could be biased
by a putative fiber type selectivity in DGAT1 overexpres-
sion, we stained serial sections with the FLAG-tagged anti-
body (green), a laminin antibody that identifies the sarco-
lemma and thus indicates individual muscle fibers (blue)




), or the FLAG-tagged antibody
(green) combined with laminin antibody (blue) and a my-
osin heavy chain 1 antibody, which can be used to identify
type I muscle fibers (red) (Fig. 1B). From Fig. 1A, B it can
be deduced that overexpression of DGAT1 did not occur
in a fiber type-selective manner.
 
Effect of DGAT1 overexpression on IMCL accumulation
 
In chow-fed rats, hardly any lipid droplets could be de-









). DGAT1 electroporation resulted in increased ac-
cumulation of lipid droplets in DGAT1-positive myocytes




). Quantification showed a significantly
increased area fraction (percent of the total cell surface
covered by lipid droplets) in DGAT1-positive myocytes





















Fig. 1. 1,2-Acyl CoA:diacylglyceroltransferase-1 (DGAT1) electropo-
ration and fiber types. Serial sections of the DGAT1-electroporated
muscle. A: The green fluorescent signal indicates the presence of
DGAT1 protein containing a FLAG-tagged epitope; lipid droplets
are stained using oil red O (in red). Myocytes are marked with I for
type I fibers. B: Type I fibers are stained in red, DGAT1 in green.
Myocytes marked with asterisks are DGAT1-positive type I fibers.
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Fig. 2. DGAT1 staining and lipid accumulation under different conditions. Staining of DGAT1-positive myocytes (in green) and lipid accu-
mulation stained with ORO (in red) in control muscle (A, B) and DGAT1-electroporated muscle (C, D) of rats fed a chow diet and in control
muscle (E, F) and DGAT1-electroporated muscle (G, H) of rats fed a high-fat diet.
 
Effect of nutritional abundance of fatty acids
on lipid accumulation
 
A high-fat diet for 15 days increased the accumulation of
lipid droplets in control muscle compared with a chow diet
(Fig. 2E, F). Quantification of the area fraction covered by
lipid droplets showed a significant increase compared with a
















 0.005; Fig. 4). However, the area fraction covered by lip-
ids on a high-fat diet was still 2.5-fold less compared with the
effect of DGAT1 overexpression on a chow diet. Moreover,
DGAT1 overexpression further increased the high-fat diet-




6-fold compared with con-
trol myocytes (Fig. 2G, H), thereby reaching the highest lev-

















 0.05; Fig. 4).
DISCUSSION
DGAT1 is known to increase triglyceride storage in
white adipose tissue, but its effect in skeletal muscle is un-
known. Therefore, the aim of the present study was to test
the role of DGAT1 in IMCL storage in skeletal muscle in
vivo. To this end, we used in vivo DNA electroporation to
 




achieve overexpression of the DGAT1 protein in living
rats. We found that in vivo DNA electroporation increased
the expression of the DGAT1 protein, which was re-
stricted to a specific muscle of interest in adult, living rats,
without affecting the muscle of the contralateral leg. We
further showed that overexpression of DGAT1 resulted in
a significant increase in IMCL content, indicating for the
first time that overexpressing DGAT1 in skeletal muscle
increases IMCL storage in vivo.
Using light microscopy, we found that in vivo DNA elec-
troporation did not affect muscle structure, as measured
15 days after electroporation. Inevitably, in vivo DNA elec-
troporation induces a certain degree of muscle damage,
as electric fields induce the transient formation of hydro-
philic pores in the cell membrane through which the
DNA can enter the myocyte. However, with the voltages
used in our study, electroporated muscles were completely
recovered by 15 days after electroporation in young adult
rats (data not shown).
It is well known, based on prior work with skeletal mus-
cle, that muscle fiber types differ greatly in their lipid con-
tent (15–17). In humans, type I muscle fibers in lean indi-
viduals as well as in obese subjects and in subjects with
type 2 diabetes mellitus have been found to contain signif-
icantly more lipid droplets than type II muscle fibers (18,
19). In addition, van Loon et al. (20) found a similar lipid
distribution among fiber types in muscle biopsies of
trained male cyclists. Therefore, DGAT1-specific overex-
pression in type I muscle fibers would confound the
DGAT1-induced increase in lipid accumulation. For this
reason, we checked whether DGAT1 transfection of myo-
cytes was restricted to specific fiber types. As can be seen
in Fig. 1, this was not the case, because DGAT1 overexpres-
sion was observed in all muscle fiber types and increased
lipid accumulation was restricted to the DGAT1-overex-
pressing myocytes. These data indicate that the effect of
DGAT1 overexpression on lipid accumulation was not de-
pendent on fiber type.
An important role for DGAT1 in triglyceride synthesis
in white adipose tissue had already been observed by
Chen et al. (11), who generated transgenic mice that over-
expressed DGAT1 by 2-fold in white adipose tissue. Repro-





triglycerides (grams per fat pad), and DGAT1-overex-
pressing mice had increased total fat pad mass as a per-
centage of total body mass compared with wild-type mice









1.20-fold) (11). Although the effects of DGAT1 overex-
pression seem less pronounced in white adipose tissue com-
pared with the results of the present study, it should be noted
that, in contrast to skeletal muscle, white adipose tissue con-




2-fold increase in adipose tissue mass induced by DGAT1
indicates a major effect on triglyceride synthesis. However,
instead of measuring relative amounts of triglycerides, our
model allows us to determine the absolute changes in in-
tramyocellular triglycerides by directly counting the sur-
face area covered by lipid droplets.
Using the electroporation technique, we found a signif-
icant overexpression of DGAT1 in almost 30% of the mus-
Fig. 3. DGAT1 protein overexpression and lipid accumulation.
Double staining of DGAT1-positive myocytes (in green; A) and cor-
responding increase of lipid accumulation stained with ORO (in
red; B). Bars  100 m.
Fig. 4. Quantification of lipid accumulation. Area fraction (per-
cent of the total cell surface covered by lipid droplets) of DGAT1-pos-
itive myocytes (black bars) and contralateral control myocytes (gray
bars) of rats fed either a chow or a high-fat diet. * P  0.05 compared
with control; ‡ P  0.05 compared with control myocytes of rats fed a
chow diet; † P  0.005 compared with DGAT1-positive myocytes of
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cle fibers. As expected, in myocytes of the contralateral in-
ternal control leg, hardly any lipid accumulation could be




0.02% of total area fraction).
However, overexpression of DGAT1 resulted in a signifi-





total cell surface covered by lipid droplets compared with
the control myocytes of the contralateral muscle. This re-
sult is even more striking given that a chow diet contains
little dietary fat. In human studies, area fractions of 3.6%
in obese individuals with type 2 diabetes mellitus (8),
3.1% in type 2 diabetic subjects, and 2.7% in trained ath-
letes (21) have been reported. Here, we show comparable
area fractions of 1.99% and 4.96% in DGAT1-positive myo-
cytes from chow-fed and high-fat-fed rats, respectively
(Fig. 4). These data suggest that DGAT1 has an important
role in triglyceride synthesis in skeletal muscle and that its
overexpression can lead to the phenotype observed in
type 2 diabetics and/or endurance-trained athletes (2, 8).
In addition, our data show that the model of in vivo
DGAT1 electroporation is an elegant tool to investigate
within one organism the effect of high versus low levels of
IMCLs on muscle metabolism while leaving whole body
metabolism unaffected.
In contrast to a chow diet, in which hardly any lipids
can be detected in normal (control) myocytes of rats, a
high nutritional abundance of fatty acids attributable to
either high-fat diets (6, 7, 22) or lipid infusions (4, 5)
leads to a rapid accumulation of lipids inside muscle in
both rats and humans within hours or days. Here, we
found that in control muscle, high-fat feeding for 15 days
(which was chosen to allow the muscle to recover from the
electroporation procedure) led to a significant increase in
the area fraction of lipid droplets compared with a chow
diet. Interestingly, however, the IMCL content after high-
fat feeding was less than 50% of the IMCL content after
DGAT1 overexpression in chow-fed rats. This further illus-
trates the potent effect of DGAT1 overexpression on
IMCL synthesis. On the high-fat diet, DGAT1 overexpres-
sion further enhanced the high-fat diet-induced lipid ac-
cumulation by 6-fold compared with the contralateral
control muscle. Thus, our results show that overexpress-
ing DGAT1 in skeletal muscle increases IMCL storage in
vivo, indicating that DGAT1 plays an important role in the
storage of triglycerides not only in white adipose tissue but
also in skeletal muscle.
Several investigations have shown that IMCL levels are
increased in type 2 diabetes (8, 23), in nondiabetic sub-
jects with insulin resistance (24, 25), in obesity (8), and in
endurance-trained subjects (21). Based on the present re-
sults, it could be speculated that increased DGAT1 expres-
sion contributes to the increased level of IMCL in these
subjects. However, little is known about DGAT1 gene ex-
pression or protein content in diabetic patients or endur-
ance-trained subjects. Ikeda et al. (26) found increased
levels of DGAT1 mRNA in muscle after a 2 week swim-
ming training in mice, which was suggested to enhance
the replenishment of triglyceride in skeletal muscles after
exercise. However, Schmitt et al. (27) found invariant lev-
els of DGAT1 mRNA between TA muscles of endurance-
trained and untrained male subjects. To the best of our
knowledge, no data are available about DGAT1 levels in
skeletal muscle of diabetic subjects or about the possible
role of DGAT1 in IMCL storage in humans. It is tempting
to speculate that DGAT1 content is increased in type 2 di-
abetic subjects, contributing to the increased IMCL stor-
age in these subjects.
In conclusion, in vivo DNA electroporation is a promis-
ing tool for the examination of the functional conse-
quences of altered gene expression in selected, mature
skeletal muscle while whole body metabolism is not al-
tered. In vivo electroporation of the DGAT1 construct in
rat TA muscle accomplished a functional overexpression
of the DGAT1 protein, leading to the accumulation of
IMCL droplets in DGAT1-positive cells. From this study, it
can be concluded that DGAT1 plays an important role not
only in the storage of lipids in white adipose tissue but
also in skeletal muscle. Future studies should focus on the
role of DGAT1 in IMCL metabolism in human subjects.
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